Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1986 1
1990 1
1991 2
1992 3
1993 1
1994 2
1996 4
1997 1
1999 3
2000 2
2001 4
2002 2
2003 3
2004 3
2005 4
2006 3
2007 4
2008 5
2009 6
2010 10
2011 10
2012 12
2013 9
2014 7
2016 3
2017 8
2018 15
2019 14
2020 15
2021 29
2022 27
2023 19
2024 19
2025 24
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Afzalibaghdad
Page 1
Did you mean n afzali baghdadabadi (1 results)?
A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.
COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators; Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, Castaldi PJ, Cho MH, Comellas AP, Conrad DJ, Curtis JL, Dass C, DeMeo DL, Dransfield MT, San José Estépar R, Flenaugh EL, Foreman MG, Fortis S, Gupta A, Han MK, Hanania NA, Hersh CP, Hokanson JE, Humphries SM, Kirby M, Kunisaki KM, Li PZ, Lynch DA, MacIntyre NR, Make BJ, Mannino DM, Martinez FJ, McEvoy CE, Miller BE, Moll M, Nakhmani A, Newell JD Jr, Pratte KA, Regan EA, Reinhardt JM, Rennard SI, Rossiter HB, Strand MJ, Suri R, Wan ES, Wendt CH, Westney GE, Wilson CG, Wise RA, Young KA, Tan WC, Silverman EK, Crapo JD. COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators, et al. JAMA. 2025 Jun 24;333(24):2164-2175. doi: 10.1001/jama.2025.7358. JAMA. 2025. PMID: 40382791 Free PMC article.
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9. Lancet. 2021. PMID: 34767764 Free article. Clinical Trial.
In part 2, 142 patients with polyarticular course JIA were assigned to tofacitinib (n=72) or placebo (n=70). Flare rate by week 44 was significantly lower with tofacitinib (21 [29%] of 72 patients) than with placebo (37 [53%] of 70 patients; hazard ratio 0.46, 95% C …
In part 2, 142 patients with polyarticular course JIA were assigned to tofacitinib (n=72) or placebo (n=70). Flare rate by wee …
Synovial tissue atlas in juvenile idiopathic arthritis reveals pathogenic niches associated with disease severity.
Bolton C, Mahony CB, Clay E, Nisa PR, Lomholt S, Hackland A, Chin PS, Smith CG, Alexiou V, Nguyen HD, Thyagarajan M, Sheikh Z, Davis P, Chippington S, Compeyrot-Lacassagne S, Davda S, Foley C, Turtsevich I, Ingledow B, Kupiec K, Kelly J, Hanlon MM, DiCarlo E, Jones LJ, Smith SL, Eyre S, Neag G, Kemble S, Madhu R, Palshikar MG, Korsunsky I, Gao C, Tran M, Dendrou C, Buckley CD, Coles MC, Raza K; MAPJAG Study Group; Gravallese E, Filer A, Wei K, Al-Abadi E, Rosser EC, Wedderburn LR, Croft AP; Multiomic Analysis of Paediatric Joint and Gut inflammation (MAPJAG) study group. Bolton C, et al. Sci Transl Med. 2025 Jul 2;17(805):eadt6050. doi: 10.1126/scitranslmed.adt6050. Epub 2025 Jul 2. Sci Transl Med. 2025. PMID: 40601776 Free PMC article.
Phase-contrast virtual chest radiography.
Häggmark I, Shaker K, Nyrén S, Al-Amiry B, Abadi E, P Segars W, Samei E, M Hertz H. Häggmark I, et al. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2210214120. doi: 10.1073/pnas.2210214120. Epub 2022 Dec 29. Proc Natl Acad Sci U S A. 2023. PMID: 36580596 Free PMC article.
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
Topp MS, Matasar M, Allan JN, Ansell SM, Barnes JA, Arnason JE, Michot JM, Goldschmidt N, O'Brien SM, Abadi U, Avivi I, Cheng Y, Flink DM, Zhu M, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Crombie JL. Topp MS, et al. Blood. 2025 Apr 3;145(14):1498-1509. doi: 10.1182/blood.2024027044. Blood. 2025. PMID: 39786390 Free PMC article. Clinical Trial.
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.
David C, Nathan N, Al-Abadi E, Arkwright PD, Bader-Meunier B, Becker S, Belot A, Brennan M, Breton S, Bondet V, Cadranel J, Coulomb l'Hermine A, De Almeida S, Duffy D, Poch TC, de Becdelièvre A, El Khalifi-Boulisfane S, Gattorno M, Gispert-Saüch M, Gothe F, Hatchuel Y, Herdliczko D, Kilinc AA, Koucky V, Labouret G, Manna R, Maillard H, Matoses Ruipérez ML, Matucci-Cerinic C, Mensa-Vilaro A, Michel K, Molina TJ, Lopez Montesinos B, Newman WG, Papenkort J, Rapp C, Rames C, Rice GI, Rose MA, Reumaux H, Sailler L, Schwerk N, Seabra L, Sellam J, Taddio A, Thumerelle C, Tommasini A, Tusseau M, Volpi S, Wetzke M, Weiss L, Welfringer-Morin A, Wislez M, Griese M, Crow YJ, Frémond ML. David C, et al. Ann Rheum Dis. 2026 Mar;85(3):547-557. doi: 10.1016/j.ard.2025.09.013. Epub 2025 Oct 25. Ann Rheum Dis. 2026. PMID: 41395910 Free PMC article.
Pulmonary involvement was observed in 34 patients, with interstitial lung disease in most cases (n = 31) and diffuse alveolar haemorrhage in 11 individuals. Twenty-six patients demonstrated joint involvement, and 7 had documented kidney disease. Previously undescribed feat …
Pulmonary involvement was observed in 34 patients, with interstitial lung disease in most cases (n = 31) and diffuse alveolar haemorr …
The efficacy of probiotics, prebiotics or synbiotics in scleroderma: A systematic review.
Wach AA, Storman D, Więckowski K, Wojtaszek-Główka M, Żabicka W, Krupka K, Abadi AK, Celińska-Löwenhoff M, Bala MM. Wach AA, et al. Clin Nutr ESPEN. 2025 Aug;68:206-215. doi: 10.1016/j.clnesp.2025.04.004. Epub 2025 Apr 29. Clin Nutr ESPEN. 2025. PMID: 40311922
The evidence suggests that probiotic intake may not affect gastrointestinal symptoms measured with Visual Analogue Scale for Gastrointestinal Tract (VAS-GIT) (change in the VAS-GIT: MD 0.04, 95% CI -0.31 to 0.40, low certainty, n = 56 probiotic group, n = 57 placebo …
The evidence suggests that probiotic intake may not affect gastrointestinal symptoms measured with Visual Analogue Scale for Gastrointestina …
Grading infantile cataracts.
Forster JE, Abadi RV, Muldoon M, Lloyd IC. Forster JE, et al. Ophthalmic Physiol Opt. 2006 Jul;26(4):372-9. doi: 10.1111/j.1475-1313.2006.00370.x. Ophthalmic Physiol Opt. 2006. PMID: 16792736
Nine cataract types were examined; nuclear (n = 9), lamellar (n = 9), posterior lenticonus (n = 4), persistent hyperplastic primary vitreous (n = 4), posterior polar (n = 3) and single cases of total, cortical, sutural and anterior polar. ...
Nine cataract types were examined; nuclear (n = 9), lamellar (n = 9), posterior lenticonus (n = 4), persistent hyperpla …
Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction.
D'Italia G, Coenen DM, Lemmens TP, Brandts L, Wielders SJH, Nagy M, Mourmans SGJ, Achten A, Al-Abadi A, Weerts J, Aizpurua AB, van Empel V, Schroen B, Cosemans JMEM. D'Italia G, et al. ESC Heart Fail. 2025 Oct;12(5):3444-3460. doi: 10.1002/ehf2.15361. Epub 2025 Jul 10. ESC Heart Fail. 2025. PMID: 40641053 Free PMC article.
METHODS: The in vivo activation of platelets, neutrophils, endothelial cells and coagulation was measured in plasma from patients with HFpEF (n = 103), age- and sex-matched controls (n = 40) and pooled plasma from a healthy reference cohort. ...
METHODS: The in vivo activation of platelets, neutrophils, endothelial cells and coagulation was measured in plasma from patients with HFpEF …
253 results